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Desorption electrospray ionization mass spectrometry (DESI MS) has gained 
significant recognition over the past few years because of its simplicity and rapid 
throughput capabilities, allowing for the direct analysis of samples with a wide variety of 
sizes, shapes, and chemistries. Addition of various reagents into the DESI spray solvent 
enables atmospheric pressure ion molecule reactions between these reagents in the 
charged micro droplets and analyte molecules on the sample surface affording improved 
selectivity and sensitivity in some cases. Presented is a rapid screening method for amino 
acids (aas) based on reactive DESI. Amino acids have been shown to play key roles in 
the regulation of cellular processes. They are also particularly vital in the determination 
of metabolic disorders such as phenylketonurea, homocystinuria, and tyrosinemia. The 
most specific and reliable methods for diagnosing these disorders are based on the 
determination of aas in body fluids using methodologies such as gas/liquid 
chromatography, tandem MS, and various combinations thereof. However, these methods 
are usually time-consuming, increasing the time physicians wait before administering 
treatment or regulating the diet of diseased infants.  
The reactive DESI approach presented here is based on the formation of stable 
noncovalent complexes between alpha-cyclodextrin (dissolved in the spray solvent) and 
amino acids present in the sample affording a selective method for their detection. 
However, the selectivity and sensitivity of screening for aas was improved by performing 
the MS analysis in the multiple reaction monitoring mode when using a quadrupole ion 
trap or by the precursor ion scan when using a triple quadrupole MS instrument, 




full scan mode. The observation of similar complexes with various carboxylic acids 
including formic acid and acetic acid, and evidence from tandem MS experiments 
indicate that amino acid:alpha-cyclodextrin complexation reactions occur by hydrogen 
bonding interaction with carboxyl group of the aas. The specificity and sensitivity 
provided by this approach seems very promising for applications in the rapid screening of 
aas directly from body fluids including urine and plasma for amino acid disorders in a 
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Desorption electrospray ionization mass spectrometry (DESI MS) is a relatively 
new analytical method that allows rapid analysis times with little sample preparation. In 
DESI MS, a pneumatically assisted electrospray plume is continuously sprayed towards 
the sampling surface, forming a thin, micron-size solvent film on the sample. Formation 
of this solvent film allows rapid extraction and/or dissolution of analyte molecules from 
the sample surface. The continuous flow of the electrospray plume momentarily replaces 
the existing solvent film by generating analyte-containing secondary droplets. The 
secondary droplets are then directed towards the inlet of the mass spectrometer.  
Although quantitative chemical analysis is not easily achievable by analysis of the 
untreated sample, the addition of an internal standard enables quantifiable results to a 
significantly accurate degree.
1
 Specifically, DESI’s rapid analysis of compounds, both 
biological and inorganic, can be used in the fast turnaround time analysis for the 
diagnosis of blood-related disorders in clinical settings such as the screening for aa 
related disorders.
2
 Amino acids are the building blocks of proteins and have many 
functions in the body. Hereditary disorders of amino acid processing can be the result of 
defects either in the breakdown of amino acids or in the body's ability to get the amino 
acids into cells.
4, 5
 The buildup of amino acids and/or by-products of amino acid 
metabolism in the blood can cause severe medical complications.
6
 Since these disorders 
produce symptoms early in life, newborns in the United States and abroad are routinely 
screened for several common disorders, such as phenylketonuria, maple syrup urine 
disease, homocystinuria, tyrosinemia, and a number of other inherited disorders.
7
 Urine 




chromatography to separate the amino acids present. Using this technique, amino acids 
form characteristic patterns on a glass plate coated with a thin layer of silica gel. The 




The presentation of the various aminoacidopathies varies from no obvious clinical 
symptoms for months (phenylketonuria), to acute encephalopathy (maple syrup urine 
disease) within days following birth.
10
 In each of these disorders, the lack of early 
identification and treatment may result in serious medical consequences including mental 
retardation, developmental delays, failure to thrive, and death.
11 
Treatment of these 
disorders is accomplished with dietary restriction of the specific amino acids and 
medication.
12
 Urea cycle disorders require treatment with low protein diets and 
medications to prevent hyperammonemia and remove toxic compounds.  Infants with 
neonatal presentations of a urea cycle disorders represent medical emergencies with 
varying outcomes.
13
 Patients typically require aggressive treatment with hemodialysis, 
which can be both painful and costly.
14
  
The present investigation reports the application of DESI MS in the reactive mode 
for the rapid detection of amino acids. Analysis of amino acid standards by reagent free 
DESI MS, in positive and negative ion mode resulted in an overall higher sensitivity in 
negative mode than positive mode, with the exception of the basic aas which showed 
higher sensitivity in positive ion mode. In an effort to improve the selectivity for the 
detection of aas, similar experiments were explored in reactive DESI mode by the 
addition of α-cyclodextrin into the spray solvent resulting in the formation of stable gas 




tandem MS analysis and by performing electrospray experiments of cyclodextrin 
solutions containing various carboxylic acids including formic and acetic acid. The 
selectivity and sensitivity for the simultaneous detection of various amino acids in the 
reactive DESI experiments was further enhanced by either performing MS analysis in the 
multiple reaction monitoring mode on a quadrupole ion trap mass spectrometer or the 
precursor ion scan using a triple quadrupole instrument, affording a 25x improvement in 






































Samples and reagents 
All reagents were used without additional purification. HPLC grade methanol 
(EMD Chemicals, Gibbstown, NJ, USA) and acetonitrile (EMD Chemicals, Gibbstown, 
NJ, USA), were used as spray solvents in the DESI experiments. HPLC grade methanol 
and ultrapure water (18.2 MΩ cm
-1
), obtained from a Nanopore purification unit 
(Barnstead, San Jose, CA, USA), were used in the amino acid standard preparation of the 
50:50 MeOH:H2O solutions. Individual crystallized amino acid samples (Sigma-Aldrich, 
St. Louis, MO, USA) were used to make the stock solutions. The stock solutions were 
made to a final concentration of 10 mM in a 50:50 MeOH:H2O mixture. The reagentless 
DESI experiments used 100% MeOH as the spray solvent. Unless otherwise stated, 30 
µM α-cyclodextrin (TCI America, Portland, OR, USA) in 50:50 ACN:MeOH was used 
as the spray solvent for the reactive DESI experiments. Industrial grade N2 (99.998% 
Airgas, Atlanta, GA, USA) was used for the nebulizer gas sprayer. 
 
DESI ion source 
A home-built DESI ion source (Figure 1) consisting of a manual X-Y and Z 
sample stage (Thorlabs, Newton, NJ) and a high-performance sprayer 
16
 was used for all 
experiments. The sprayer was fixed to a post which was mounted on a MicroBlock 3-axis 
positioner (Thorlabs, Newton, NJ) allowing manual adjustments of the emitter position in 
the XYZ coordinates, respective to the capillary inlet. This sprayer holder assembly was 




The X-Y stage which allows sample translation in the x-y axis was mounted atop 
a heavy duty lab jack (Thorlabs, Newton NJ) for manual adjustment of the sample 
position in the z-axis. The lab jack-stage assembly was also affixed to the bread board. 
Samples were held in place using two Al sample holders (110 x 10 x 3 mm) mounted on 
the sample plate of the microscope stage. The sprayer tip was positioned 2–3 mm from 
the capillary inlet and 0.1-1 mm away from the surface of the sample at an angle of 55
o
.  
The collection angle was set ~10
o
. The DESI spray solutions were delivered to the 
sprayer at a flow rate of 5 µL/min via a syringe pump and a 250 mL glass syringe 
(Hamilton Company, Reno, NV). Solvents were administered through two pieces of 
PTFE tubing (127 mm id) connected through a T union with one end connected to the 
sprayer and the other end to the syringe. Spray solvents were charged to +/-3 kV 
(depending on positive or negative ion mode) by an external high voltage power supply 
(Stanford Research Systems Inc., Sunnyvale, CA). The power supply was in electrical 
contact with the spray solution through one port of a T union. The N2 nebulizer gas 
pressure was set to 110 psi. 
 
Mass Spectrometry 
DESI MS experiments were performed on a Thermo Finnigan LCQ Deca XP+ 
quadrupole ion trap
2
 (Thermo Fisher Scientific, San Jose, CA, USA)  and on an Agilent 
6410 series triple quadrupole mass spectrometer (Agilent Technologies, Santa Clara, CA, 
USA). The standard ion transfer capillary of the ion trap instrument was replaced with an 
extended version (20.5 cm long, 762 µm i.d., 1588 µm o.d. Small Parts Inc., Miramar, 




capillary of the QqQ instrument through a custom made Vapur-type interface to enable 
DESI MS investigations. Initial optimization experiments for the evaluating of the 
individual aas and mixtures of those commonly presented in aa disorders were performed 
by reagentless and reactive DESI on the QiT MS instrument. Selectivity and sensitivity 
improvements for the targeted analysis of amino acid mixtures, was achieved following 
preprogrammed MRM transitions on the QiT instrument and compared with similar 
analysis on a triple quadrupole instrument using a precursor ion scan experiments. 
 
RESULTS and DISCUSSION 
Analysis of 18 naturally occurring amino acids evaluated in this study was first 
assessed in positive ion mode and then in negative ion mode. Figure 2 shows a typical 
DESI MS spectrum for this analysis, in this case phenylalanine analyzed in (a) positive 
ion mode and (b) negative ion mode. Analysis in either mode reveals peaks 
corresponding to phenylalanine monomer and dimer species, observed as protonated 
analyte species in positive ion mode and deprotonated species in negative ion mode. 
Sodiated aa species were also observed in positive mode in some cases. Overall, for all 
the aas evaluated, the negative ion mode showed superior performance over the positive 
ion mode resulting in cleaner spectra with fewer chemical background peaks; possibly 
due to the inability of these background species to ionize in negative ion mode. Table 1 
shows a comparison of the detection limits obtained for each amino acid in both positive 
and negative mode. For all the aas evaluated, the negative ion mode resulted in better 
detection limits than the positive ion mode except for the aas with basic side chain such 




their high proton affinities. Aspartic and glutamic acid were only observed in the negative 
ion mode at the concentrations evaluated. The acidic nature of the molecules may be the 
cause of this phenomenon, as it would greatly impede the protonation of the molecules in 
positive mode. Tyrosine was not detected at these levels in either mode. 
In an effort to increase the selectivity and hopefully the sensitivity in the detection 
of amino acids, and for potential applications of their detection in complex mixtures, the 
experiments were reevaluated in the reactive mode. Various cyclodextrins including α- 
and β-cyclodextrin were evaluated as chemical agents for the selective recognition of 
amino acids by complexation reactions. Only α-cyclodextrin was observed to form stable 
gas phase complexes with the amino acids which were detected in negative ion mode as 
the deprotonated complexes. Various concentrations of α-cyclodextrin were evaluated for 
the analysis of methionine standards, resulting in 30 µM α-cyclodextrin as the optimum 
concentration. Figure 3 shows representative reactive DESI MS spectra of (a) 
phenylalanine, (b) aspartic acid and (c) glutamic acid with the optimized conditions. Only 
one analyte peak is observed in all three examples, assigned as their corresponding 
complexes with α-cyclodextrin, thereby affording a very selective method for their 
detection. These assignments were verified by tandem MS analysis of the peaks 
corresponding to each of the amino acid:α-cyclodextrin complexes. All 18 amino acids 
investigated in this study were detected within the evaluated concentration levels using 
the reactive DESI MS approach. This also resulted to an overall increase in sensitivity for 
all the aas as shown by the lower detection limits, Table 1, except for the aas with basic 
side chains (lysine, histidine and arginine) which showed the best sensitivity in the 




Tandem MS analysis of the deprotonated amino acid:α-cyclodextrin complexes 
resulted in the liberation of the neutral aa with the deprotonated α-cyclodextrin as the 
major product ion in the spectrum. This suggests that the complexes are most likely 
formed in solution/droplets by interactions of the carbonyl group of the aas with the 
deprotonated α-cyclodextrin, through hydrogen bonding interactions. Further support for 
this hypothesis was verified by the observation of similar complexes with formic and 
aspartic acid following ESI experiments of α-cyclodextrin solutions containing these 
acids (Figure S-1) in full scan and MS/MS modes. The observation of peaks 
corresponding to these acids in the full scan reactive DESI spectra indicated the presence 
of these acids as impurities in the spray solvent. The presence of these carboxylic acid 
impurities in the spray solvent, competing for reaction with the α-cyclodextrin limits the 
amount of this reagent available for reaction with the analyte, potentially resulted in 
ionization suppression. As such all reactive DESI spectra acquired in full scan mode were 
acquired in the 1050-1500 m/z range (above the m/z for the carboxylic acid, impurity 
complexes) with AGC, or auto-gain control, on in order to improve the sensitivity for 
detection of the amino acid (analyte) complexes.  
The performance of the optimized reactive DESI MS approach was evaluated for 
the simultaneous determination of an equimolar mixture of aas (leucine, isoleucine, 
methionine, phenylalanine, tyrosine, and valine) commonly encountered during the 
clinical evaluation of aa disorders. Initial evaluation of the relative gas phase stability of 
each of these aa following their respective break down curves suggested that each of 
these aa-α-cyclodextrin complexes showed similar gas phase stabilities indicating the 




Simultanoeus detection of each of the 6 aa in equimolar mixture was performed by 
reactive DESI coupled to a QiT mass spectrometer in the full scan (Figure S-2) and 
MRM modes following various programmed transitions which resulted in the neutral loss 
of each of the individual aas in the mixture. The sensitivity for the detection of each of 
these aas was then compared with similar analysis on a QqQ mass spectrometer in full 
scan (Figure 5a) and in the precursor ion scan (m/z 971, with the neutral loss of each aa, 
Figure 5b). The full scan spectra collected with both instruments resulted in the 
unambiguous simultanoeus detection of all 6 aas investigated with the analysis performed 
on the QqQ instrument showing better sensitivity (see Table 2). The selectivity for the 
detection of each of the aas in the mixture was improved by performing the analysis in 
the MRM mode for the QiT and precursor ion scan in the QqQ instruments. In this case 
the QiT instrument showed superior sensitivity probably because the AGC capabilities of 
the QiT which allowed for the ion trap to selectively accumulate ions of interest during 
MRM experiments.  Applications of this protocol for the direct determination of aas in 
human serum samples are currently underway. 
 
CONCLUSIONS 
The presented investigations indicate that DESI MS can serve as a rapid method 
for the detection of amino acids at concentrations comparable to those found in human 
serum samples. The detection limits were in the general regimes of the expected amino 
acid concentrations in normal human serum. Reagentless DESI MS analysis enabled the 
detection of all 18 aa investigated, however with limited sensitivity and selectivity, which 




optimized reactive DESI protocol enabled the simultaneous determination of a 6 aa 
commonly encountered during aa related disorders with the sensitivity for the detection 
of each aa improved by performing the analysis in the MRM mode when analysis is 
formed on a QiT and the precursor ion scan for analysis on a QqQ instrument. Further 
experiments are currently underway to adapt this analytical protocol for the direct 
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Figure 1: Schematic of the DESI set-up showing the sprayer, sampling platform, and 
mass spectrometer inlet capillary. 
 
Figure 2: DESI spectra of 5 µL, 1 mM phenylalanine standards spotted onto PTFE 
coated glass slides and air dried prior to analysis in (a) positive ion mode and (b) negative 
ion mode.  
 
Figure 3: Reactive DESI spectra using 30 μM α-cyclodextrin solvent spray for the 
analysis of amino acid standards (5 µL, 1 mM ) that were deposited onto PTFE coated 
glass slides and air dried prior to analysis: (a) phenylalanine; (b) aspartic acid; (c) 
glutamic acid. The inserts show the corresponding MS/MS spectrum of each of the amino 
acid complexes with α-cyclodextrin.  
 
Figure 4: Breakdown curves of various amino acid:α-cyclodextrin complexes including: 
valine, phenylalanine, methionine, leucine and isoleucine. 5 µL, 1 mM of each amino 
acid samples was spotted onto PTFE coated glass slides, air dried, then analyzed with a 
spray solution containing 30 μM of α-cyclodextrin in 50:50 MeOH:ACN.  
 
Figure 5: Spectra obtained by spotting 5 µL of an equimolar (1 mM) mixture of amino 
acids including: valine, phenylalanine, methionine tyrosine, leucine and isoleucine onto 
PTFE coated glass slides, air dried, then analyzed with a spray solution of 30 μM of 
α-cyclodextrin in 50:50 MeOH:ACN. (a) full scan mode and (b) precursor ion scan of m/z 















Table 1: Limit of detection values based on individual amino acid standards. These are 
compared to literature values that are consistent with human serum levels. (*Calculated at 
signal-to-noise ≥ 3) 
 
Table 2: Limit of detection values based on an equimolar (1 mM) mixture of amino acids 
including: valine, phenylalanine, tyrosine, leucine and isoleucine. The MRM limit of 
detection was found through a serial dilution of the amino acid mixture. These are 
compared to literature values that are consistent with human serum levels. (*Calculated at 
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[cyclodextrin + Phe - H]-
1136.4
[cyclodextrin + Glu - H]-
1118.1
[cyclodextrin + Asp - H]-
1104.2
m/z


























































































































m/z 1088.4: [-cyclodextrin+Val - H]-
m/z 1102.3: [-cyclodextrin+Leu/Ile - H]-                  
m/z 1120.3: [-cyclodextrin+Met - H]-
m/z 1136.5: [-cyclodextrin+Phe - H]-

























5μL  human 
serum (nmol)
18
Alanine 1.85 0.90 0.58 - 1.665 ± 0.370
Arginine 0.82 0.74 2.76 - 0.400 ± 0.100
Aspartic Acid ND 0.83 0.52 - 0.015 ± 0.005
Glutamic Acid ND 2.43 0.18 - 0.120 ± 0.075
Glutamine 7.05 4.14 0.91 - 2.930 ± 0.420
Glycine 2.65 2.24 0.44 - 1.150 ± 0.260
Histidine 0.35 0.30 4.15 - 0.410 ± 0.050
Lysine 0.52 1.04 0.91 - 0.940 ± 0.160
Proline 2.33 1.09 0.99 - 0.840 ± 0.300
Serine 3.96 0.58 0.50 - 0.570 ± 0.095
Threonine 7.13 0.90 0.55 - 0.700 ± 0.165
Tryptophan 2.06 3.25 0.77 - 0.220 ± 0.035
Isoleucine 3.51 2.07 0.26 0.19 0.310 ± 0.070
Leucine 3.96 2.52 0.35 1.95 0.615 ± 0.125
Methionine 1.98 0.62 0.85 0.31 0.125 ± 0.020
Phenylalanine 3.29 0.45 0.45 0.11 0.285 ± 0.045











Methionine 0.67 0.068 0.17 1.79
Phenylalanine 0.87 0.068 0.11 0.91
Tyrosine 2.89 0.002 2.20 ND
Valine 5.62 0.014 0.73 7.43
QiT LOD (nmol) QqQ LOD (nmol)
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